Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis

Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.

Detalles Bibliográficos
Autores principales: Call, John E., Sahni, Sakshi, Zug, Kathryn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455431/
https://www.ncbi.nlm.nih.gov/pubmed/32884748
http://dx.doi.org/10.1002/ccr3.2915
_version_ 1783575623867826176
author Call, John E.
Sahni, Sakshi
Zug, Kathryn A.
author_facet Call, John E.
Sahni, Sakshi
Zug, Kathryn A.
author_sort Call, John E.
collection PubMed
description Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata.
format Online
Article
Text
id pubmed-7455431
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74554312020-09-02 Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis Call, John E. Sahni, Sakshi Zug, Kathryn A. Clin Case Rep Case Reports Recent studies have demonstrated significant molecular parallels between atopic dermatitis and alopecia areata as predominantly TH2‐mediated diseases. This case report highlights the potential for Dupilumab as a targeted biologic therapy in both atopic dermatitis and alopecia areata. John Wiley and Sons Inc. 2020-05-25 /pmc/articles/PMC7455431/ /pubmed/32884748 http://dx.doi.org/10.1002/ccr3.2915 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Call, John E.
Sahni, Sakshi
Zug, Kathryn A.
Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title_full Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title_fullStr Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title_full_unstemmed Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title_short Effectiveness of Dupilumab in the treatment of both atopic dermatitis and alopecia universalis
title_sort effectiveness of dupilumab in the treatment of both atopic dermatitis and alopecia universalis
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455431/
https://www.ncbi.nlm.nih.gov/pubmed/32884748
http://dx.doi.org/10.1002/ccr3.2915
work_keys_str_mv AT calljohne effectivenessofdupilumabinthetreatmentofbothatopicdermatitisandalopeciauniversalis
AT sahnisakshi effectivenessofdupilumabinthetreatmentofbothatopicdermatitisandalopeciauniversalis
AT zugkathryna effectivenessofdupilumabinthetreatmentofbothatopicdermatitisandalopeciauniversalis

Ejemplares similares